Cargando…
Optimizing Rhabdomyosarcoma Treatment in Adolescents and Young Adults
SIMPLE SUMMARY: Due to their rarity, we still know comparatively little about rhabdomyosarcomas (RMS) in adolescents and young adults (AYA). Factors responsible for the significantly poor outcomes in AYA-RMS are tumor biology, physiological factors specific to the age group concerned, refractoriness...
Autor principal: | Makimoto, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105996/ https://www.ncbi.nlm.nih.gov/pubmed/35565399 http://dx.doi.org/10.3390/cancers14092270 |
Ejemplares similares
-
Rhabdomyosarcoma in adolescent and young adult patients: current perspectives
por: Egas-Bejar, Daniela, et al.
Publicado: (2014) -
Shedding a Light on the Challenges of Adolescents and Young Adults with Rhabdomyosarcoma
por: Ferrari, Andrea, et al.
Publicado: (2022) -
Paratesticular rhabdomyosarcoma of a young adult
por: Matovina-Brko, Gorana, et al.
Publicado: (2015) -
Pelvic alveolar rhabdomyosarcoma in a young adult
por: Reisner, David, et al.
Publicado: (2015) -
Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients
por: Dumont, Sarah N, et al.
Publicado: (2013)